Brown University
Back to Results

Variation in the use of bevacizumab and ranibizumab for branch retinal vein occlusion

Description

Abstract:
To describe frequency and variation of intravitreal bevacizumab and ranibizumab use for branch retinal vein occlusion (BVO) in the United States (US) with the aim of improving cost effective ophthalmic treatment utilization.

Citation

Yu, Fei, Wu, Annie M., Wu, Connie M., et al., "Variation in the use of bevacizumab and ranibizumab for branch retinal vein occlusion" (2017). Warren Alpert Medical School of Brown University Scholarly Concentrations Program Gallery of Scholarly Work, Warren Alpert Medical School Academic Symposium. Brown Digital Repository. Brown University Library. https://doi.org/10.26300/dmpp-2e19

Relations

Collections: